Baxter Healthcare product recalled over sterility concerns
- Recall date
- July 18, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Baxter Healthcare Corporation recalls 0.9% Sodium Chloride Injection USP, 100 mL Viaflex Container, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 600…
- Recall number
- D-1514-2019
- FDA classification
- Class II
- Brand / firm
- Baxter Healthcare Corporation
- Sold / distributed
- Nationwide in the United States and Puerto Rico.
Why it was recalled
Lack of Assurance of Sterility: Bags have potential to leak.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
0.9% Sodium Chloride Injection USP, 100 mL Viaflex Container, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-0049-38.
Get recall alerts
Free email alert whenever Baxter Healthcare Corporation has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Baxter Healthcare Corporation